Coulter Partners provides leadership consultancy to Life Sciences, Health and Technology innovation businesses globally. We build teams that change the world and create a better future. Over 20 years we have delivered on 1000s of assignments across the USA, Canada, UK/Europe, and APAC, advising companies and investors on how to shape and hire their boards and leadership teams. We strongly impact value and growth. Our 110 experts operate uniquely as one global team. With our track record, AI, bespoke systems and wealth of data, we fuel the ability of investors, boards and executive teams to deliver value from innovation.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Global executive search firm Coulter Partners has placed Emilie Viey as the new CEO of Ovizio Imaging Systems, a life science imaging technology company. Philip Mathuis, who co-founded Ovizio, recently stepped down. Philipp Buis, Coulter’s executive director, led the assignment. Dr. Viey will lead Ovizio’s further development as solution provider for imaging applications in life sciences.
Global executive search firm Coulter Partners recently made eight new appointments in the U.S., Denmark and at their London headquarters. In the U.S., Noah Parekh joins as client partner in Cambridge, MA, while Lisa Pieper has been appointed consulting partner in Palo Alto, CA, and Adrienne Slutzky joins as project coordinator in Short Hills, NJ. In London,
Global executive search firm Coulter Partners recently opened a new office in Pittsburgh and brought in research analysts Rachel Matos and Rebecca Russell to work at that location. Coulter Partners’ London headquarters, meanwhile, consolidated its research analyst capability with the appointment of Matthew Dennehy. “We are delighted to be investing in new technologies and skills both in
Executive search firm Coulter Partners has placed Phil Offer as the new CEO of George Health Technologies. Based in Sydney, Australia, his primary focus will be to develop the company’s business growth strategy and commercial opportunities. “This was a truly global search for a truly global role and we developed multiple candidate relationships, in multiple time zones,”
LONDON, U.K., November 8, 2016 — Coulter Partners was delighted to partner once more with Erytech Pharma to secure the appointment of Dr. Alexander Scheer as Chief Scientific Officer. ERYTECH Pharma (Euronext Paris:ERYP) (Paris:ERYP) (ADR:EYRYY) is a French biopharmaceutical company developing ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs. “Alexander brings a
LONDON, U.K., September 21, 2016 — Coulter Partners consolidates global team with appointments in New Jersey, Newton and London. Global Life Sciences search specialist, Coulter Partners is pleased to announce a number of new appointments in the U.S. and in London. Jo Anne Patrick and Mat Rosso both join as Principals in Morristown New Jersey, while Jonathan Deacon
LONDON, U.K., September 8, 2016 — Coulter Partners was delighted to partner with Erytech Pharma to secure the appointment of Allene M. Diaz to its Board of Directors as a nonvoting member (censeur). ERYTECH Pharma (Euronext Paris:ERYP) (Paris:ERYP) (ADR:EYRYY) is a French biopharmaceutical company developing ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet
LONDON, U.K., May 23, 2016 — Coulter Partners has placed Dr Richard Butt as Chief Executive Officer for Apollo Therapeutics, the investment fund focused on driving therapeutic innovation through university collaboration. Apollo Therapeutics is a unique alliance between three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline and Johnson & Johnson) and the technology transfer offices (TTOs) responsible for commercialising the
LONDON, U.K., May 12, 2016 — Global Life Sciences search specialist, Coulter Partners is pleased to announce the appointment of James Bichener as Finance Director. James brings a wealth of financial expertise gained both within executive search and beyond to augment the strategic strengths of the senior management team. “We are extremely fortunate to attract such a
Blogs
Top hires for VC & PE portfolio companies Q1-2024
D, E & I: VIEWS FROM LEADERSHIP SERIES – Lene Gerlach, Founder and Chair of Women in Life Science Denmark (WiLD), and Partner at Eir Ventures
D, E & I: VIEWS FROM LEADERSHIP SERIES – Yael Gruenbaum-Cohen, Partner at aMoon and Founder of WE@HealthTech
Top hires for VC & PE portfolio companies Q4-2023
Top global hires for large-cap, mid-cap and public companies H2-2023
Top hires for VC & PE portfolio companies Q3-2023
Top hires for VC & PE portfolio companies Q2-2023
Top global hires for large-cap, mid-cap and public companies H1-2023
Top hires for VC & PE portfolio companies Q1-2023
D, E & I: Views From Leadership Series – Charlotte Valeur, Founder of Institute Of Neurodiversity, ION
Top hires for VC & PE portfolio companies Q4-2022
Top global hires for large-cap, mid-cap and public companies H2-2022
Diversity, Equity, & Inclusion: Views From Leadership Series- Quita Highsmith, Vice President and Chief Diversity Officer at Genentech
Diversity, Equity & Inclusion: Views from Leadership-Tomoko Adachi
Diversity, Equity & Inclusion: Views from Leadership-Corinne Le Goff